# Efficacy of Guselkumab in Treating Hailey Hailey Disease

> **NCT06651489** · PHASE2 · RECRUITING · sponsor: **Yale University** · enrollment: 10 (estimated)

## Conditions studied

- Hailey Hailey Disease

## Interventions

- **DRUG:** Guselkumab

## Key facts

- **NCT ID:** NCT06651489
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-13
- **Primary completion:** 2026-04
- **Final completion:** 2026-04
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06651489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06651489, "Efficacy of Guselkumab in Treating Hailey Hailey Disease". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06651489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*